Sr/Exec Director GI Medical Strategy
About the role
About Erasca
Erasca is a clinical-stage precision oncology company focused on discovering, developing and commercializing medicines for the benefit of patients with cancer. Our programs take novel approaches to shutting down one of cancer’s most commonly mutated signaling cascades, the RAS/MAPK pathway, which affects approximately 5.5 million lives each year worldwide. The name “Erasca” has an important embedded meaning: it is a contraction of our audacious hope to “erase cancer” that drives our mission and everything that we do on behalf of patients with cancer.
Position Summary
Reporting to the VP of Medical Affairs, the Senior or Executive Director, GI Medical Strategy will drive the overarching medical strategy and execution for GI cancers with a focus toward pancreas cancer. This person will work closely with cross-functional teams in the development, management, and execution of the clinical development plan, evidence generation strategy, scientific narrative, and KOL engagement strategy. The Senior or Executive Director, GI Medical Strategy will serve as a GI cancers subject matter expert and key thought partner, both internally and externally, and will have individual responsibility for growing and developing the medical affairs function within GI cancers at the company.
Note that this position can be hybrid in San Diego, CA or South San Francisco, CA or fully remote anywhere in the United States.
Essential Duties and Responsibilities
- Strategic and tactical lead for GI cancers in Medical Affairs. Coordinates across all Medical Affairs, R&D, and other functions by developing and maintaining strategic plans and budgets.
- Partners across internal stakeholders in the development of the GI cancers overall medical strategy, clinical development plan, evidence generation strategy, scientific narrative, and KOL engagement strategy.
- Collaborates and drives GI cancers tactical planning. Manages execution of Medical Affairs activities including publication development, insight generation initiatives, medical communications, evidence generation, training, and early access.
- Serves as a subject matter expert in gastrointestinal oncology with an emphasis on precision therapeutics in pancreas cancer.